This move is archived. Current quotes and coverage live on the stock page.
Get TELY alerts:
TelyRx Holdings Inc. faces a steep decline as investors react to its latest financial performance.
In the latest trading session, TelyRx Holdings Inc. (TELY.TO) saw its stock price drop by 10.91%, closing at CA$2.45. This significant decline raises concerns about the company's financial health and investor sentiment.
Investor takeaway: TelyRx's recent performance highlights the volatility often seen in emerging healthcare companies, especially those still grappling with substantial losses despite increasing revenues.
Advertisement
TelyRx Holdings Inc.
TELY.TO
TELY.TO
TelyRx Holdings Inc.
WealthAwesomeMarket cap
$66.48M
52W high
$4.25
52W low
$2.00
1W change
-1.96%
Analyst Price Targets
Based on analyst covering TELY
Wall Street analysts forecast TELY stock price to rise 140.0% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$6.00
+140.0% Upside
Current Price
C$2.50
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELY's historical volatility
30-Day Vol
99.3%
Annualized
90-Day Vol
95.6%
Annualized
Trend (90d)
+17.1%
Annualized drift
90d Mean
C$2.66
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$2.55 | C$1.81 โ C$3.59 |
| 60 trading days | C$2.60 | C$1.60 โ C$4.23 |
| 90 trading days | C$2.66 | C$1.47 โ C$4.81 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
TelyRx Holdings Inc. sees a 10.91% drop in stock price.
Advertisement
The company's market cap now stands at CA$73,091,416, reflecting investor concerns over its profitability and future outlook.
Bull case
Despite the downturn, TelyRx reported a notable revenue increase in Q1 2026, suggesting potential for future growth if they can manage their losses effectively. The revenue rose to CA$19.4 million, up from CA$6.9 million in the same quarter last year. This shows that while the company is struggling with losses, it is also making strides in generating sales, which could set the stage for a turnaround.
Bear case
However, the company's net loss of CA$4.7 million and a profit margin of -18.17% indicate ongoing financial struggles. These factors may deter investors looking for stability, as many are concerned about whether TelyRx can sustain its business model in a competitive healthcare market. The stark contrast between rising revenues and persistent losses raises red flags for potential investors.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile โโ Reviewed by Certified Financial Professionals
This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
โ ๏ธ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
